Cafepharma Today

June 11 2021 - FDA tells JNJ to throw out 60 million doses of COVID vaccine made at troubled plant
FDA tells JNJ to throw out 60 million doses of COVID vaccine made at troubled plant
Sanofi's treatment for rare anemia hits 2nd endpoint in phase 3
DOJ investigation remains even after an internal probe at Lilly plant found the company didn't mislead FDA
Ocugen plans to seek full FDA approval for Covaxin vaccine
*please scroll down for all the latest news*

Stay updated with the latest pharma-related coronavirus news on our new page

Today's most popular searches:

Current News

submit a press release

Click here to stay updated on CP happenings
FDA panel split on approach to COVID-19 vaccines for younger children
RAPS.org
Saturday, June 12, 2021 - 10:34pm
tags:
FDA, vaccines, COVID-19, pediatric
Has Illumina Lost Its Shine?
Motley Fool
Saturday, June 12, 2021 - 10:31pm
tags:
Illumina, diagnostics
7 Moments in 2021 Destined to Change the Cardio-Device Industry Forever
Medical Devices and Diagnostics Industry
Saturday, June 12, 2021 - 10:29pm
tags:
devices, cardiovascular disease, Medtronic, LivaNova, Google, AliveCor, Abbott Labs
EHA21: Novartis trumpets iptacopan as oral alternative to antibodies in PNH
Pharmaforum
Saturday, June 12, 2021 - 10:26pm
tags:
Novartis, iptacopan, clinical trials, PNH, EHA
Bayer pledges $300M to boost production in world's 'contraceptive capital’
Fierce Pharma
Saturday, June 12, 2021 - 10:25pm
tags:
Bayer, Europe, drug manufacturing, contraceptives
Incyte hits 2nd FDA delay in span of days, this time for atopic dermatitis hopeful ruxolitinib cream
Fierce Pharma
Saturday, June 12, 2021 - 10:23pm
tags:
Incyte, atopic dermatitis, ruxolitinib, FDA
The F.D.A. tells Johnson & Johnson that about 60 million doses made at troubled plant cannot be used.
NY Times, NY
Friday, June 11, 2021 - 12:12pm
tags:
JNJ, vaccines, COVID-19, drug manufacturing, FDA, Emergent BioSolutions
Eli Lilly, Roche's Alzheimer's prospects, including flops, boosted in light of FDA's Aduhelm approval: analysts
Fierce Biotech
Friday, June 11, 2021 - 12:10pm
tags:
Eli Lilly, Roche, Biogen, Alzheimer's disease, FDA, beta-amyloid plaque
GSK reveals 26 million Americans skipped routine vaccinations last year, quantifying widely held suspicions
Fierce Pharma
Friday, June 11, 2021 - 12:05pm
tags:
GSK, vaccines, routine vaccinations, pandemic, COVID-19
Johnson & Johnson's COVID-19 vaccine scores longer shelf life just as millions of doses were set to expire
Fierce Pharma
Friday, June 11, 2021 - 10:57am
tags:
JNJ, vaccines, COVID-19, logistics, FDA
Fresh off $598M deal with Novo Nordisk, a Japanese stem cell company is on its way to the clinic with a different approach to treating heart failure
Endpoints
Friday, June 11, 2021 - 10:56am
tags:
heart failure, Heartseed, Japan, Novo Nordisk, stem cells
Lilly's internal probe into Branchburg, New Jersey, plant found company didn't mislead FDA, but DOJ investigation remains: report
Fierce Pharma
Friday, June 11, 2021 - 10:54am
tags:
Eli Lilly, DOJ, drug manufacturing, FDA
Sanofi's treatment for rare anemia hits goal in 2nd phase 3
Fierce Biotech
Friday, June 11, 2021 - 10:52am
tags:
Sanofi, clinical trials, sutimlimab, cold agglutinin disease
Ocugen plans to seek full approval for Covaxin in US
Pharmaceutical Business Review
Friday, June 11, 2021 - 10:51am
tags:
Ocugen, Covaxin, FDA, vaccines, COVID-19
BMS will file for earlier-line use of Breyanzi in lymphoma after trial win
Pharmaforum
Friday, June 11, 2021 - 10:49am
tags:
Bristol Myers Squibb, CAR-T, Breyanzi, large B-cell lymphoma, Novartis, Gilead Sciences, FDA
CVS drug buyers say pharmacy overcharged them $100M as trial opens
MedCity News
Friday, June 11, 2021 - 10:47am
tags:
drug pricing, CVS Health, legal, payers
Health tech SPAC deals on pause
EP Vantage
Friday, June 11, 2021 - 10:46am
tags:
SPAC, M&A, SEC
Despite Hitting Mid-Stage Trial Endpoint Goal, Vertex Strikes Out Rare Lung Disease Candidate; Stock Tumbles
Yahoo/Benzinga
Friday, June 11, 2021 - 10:45am
tags:
Vertex Pharmaceuticals, VX-864, alpha-1 antitrypsin deficiency, clinical trials
80% of pharma workers think Aduhelm's approval was a mistake, survey says
Beckers Hospital Review
Thursday, June 10, 2021 - 11:50pm
tags:
Biogen, Aduhelm, FDA, Alzheimer's disease
Third member of FDA expert committee resigns over controversial Alzheimer’s therapy decision
Stat
Thursday, June 10, 2021 - 11:48pm
tags:
FDA, Alzheimer's disease, Biogen, Aduhelm

Pages

Latest CP Wire Articles

Sirona Biochem's Innovations in Biotechnology Lead to Safer, More Effective Cosmetic and Pharmaceutical Active Ingredients
Vaccinated? Don’t Let Your Guard Down Just Yet, says Ohio Math Expert
High School Student Calls On Pharmaceutical Industry To Fund The Planting of 1 Million Trees In 5 Years In National Forests To Increase HCP Access
5 Ways Telemedicine Is Helping Health Care Providers In 2021[sponsored]
“Special Fraud Alert” Targets Pharma & Medical Device Speaker Programs
Launch of Unprecedented Biotech Data Resource
Bigfinite is Now Aizon
SIFI reports positive results from 044/si phase 3 clinical trial further highlighting strength of its NETILDEX® franchise
Highlights: 2020 Cardiometabolic Health Congress West Live Online
Chelation Partners Announces Issuance of U.S. Patent Covering Composition of Matter for DIBI and Related Compounds for Controlling Infections

Latest Pharmagather Articles

The Top Five Considerations When Choosing a Patient Solutions Provider
Drug Channels
An Update on Global Availability of COVID-19 Vaccines from Editor of The Lancet
Elsevier
Days Off
In the Pipeline
The Aducanumab Approval
In the Pipeline
Pharmacist Job Market in 2020: Hospital Employment Up, Retail Salaries Down
Drug Channels
Ivermectin As a COVID-19 Therapy
In the Pipeline
National Association of Specialty Pharmacy (NASP) 2021 Annual Meeting & Expo
Drug Channels
Technology and Human Care Combine to Support the Medication Access Journey
Drug Channels
4 Notable Life Sciences Trends from the Tech Trends Report
Elsevier

Pharma and Device News from NASDAQ

Global Enteral Nutrition Market (2020 to 2027) - by Protein Composition, Form, Age Group and Distribution Channel
Friday, June 11, 2021 - 8:03am
atai Life Sciences Announces Launch of Initial Public Offering
Friday, June 11, 2021 - 7:59am
Insights on the Blood Gas and Electrolyte Analyzer Global Market to 2026 - Featuring Abbott Laboratories, Bayer and Edan Instruments
Friday, June 11, 2021 - 7:28am
Global 3D Printing Medical Devices Market (2021 to 2026) - Direct Digital Manufacturing Presents Opportunities
Friday, June 11, 2021 - 6:13am
Global Pharma and Biotech Dealmaking Royalty Rate Trends Report 2021
Friday, June 11, 2021 - 5:43am
Agios Presents Positive Results from Phase 2 Study of Mitapivat in Non-transfusion-dependent α- and β-Thalassemia at the European Hematology Association Virtual Congress
Friday, June 11, 2021 - 3:00am
Agios Announces Updated Data from ACTIVATE and ACTIVATE-T Phase 3 Studies of Mitapivat in Pyruvate Kinase (PK) Deficiency at the European Hematology Association Virtual Congress
Friday, June 11, 2021 - 3:00am
OliX Pharmaceuticals to Conduct One-on-One Meetings with Potential Partners at BIO Digital 2021 Conference
Thursday, June 10, 2021 - 3:00pm
CVRx® Announces First Clinical Procedure with a New Ultrasound-Guided Implant Approach, the Latest Advancement in Barostim™ for the Treatment of Heart Failure Symptoms
Thursday, June 10, 2021 - 11:19am
Onconova Therapeutics Announces Participation in A.G.P.’s Upcoming Virtual Summer Healthcare Symposium
Thursday, June 10, 2021 - 8:00am

Want to host your own webinar?

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information